Skip to main content
Equibles
LFCR logo

LFCR · Lifecore Biomedical, Inc. De · Webcasts, Transcripts & Audio

Track LFCR — free

Use LFCR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LFCR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.50 +0.06 (+0.85%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$243.77M
Shares
37.85M
Volume · Oct 28 248.28K Avg daily vol (3M) 351.48K

Lifecore Biomedical, Inc. De Webcasts

Earnings calls, investor updates, investor days and conferences for Lifecore Biomedical, Inc. De (LFCR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-05
Lifecore Biomedical, Inc. De (LFCR) Q2 2026 Earnings Call Transcript
Confident tone New business wins and business development momentum Development pipeline progress Largest customer demand inflection
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Lifecore Biomedical, Inc. De (LFCR) Q1 2026 Earnings Call Transcript
Positive tone Guidance reaffirmation and revenue trajectory Cost reduction and margin improvement New commercial site transfers and pipeline wins
Revenue
$31.11M
▲ 25.9% YoY
Diluted EPS
$-0.29
Gross margin
25.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-03-16
Lifecore Biomedical, Inc. De (LFCR) Q4 2026 Earnings Call Transcript
Positive tone Cost reduction and margin improvement Business development and new program wins Late-stage pipeline development and commercialization
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q4
2025-08-07
Lifecore Biomedical, Inc. De (LFCR) Q4 2025 Earnings Call Transcript
Confident tone Financial guidance and midterm targets ERP implementation and operational investments Tariffs and onshoring tailwinds
Revenue
$36.44M
▼ 3.8% YoY
Diluted EPS
$-0.06
Gross margin
38.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-04-03
Lifecore Biomedical, Inc. De (LFCR) Q3 2025 Earnings Call Transcript
Positive tone Revenue and earnings results Customer pipeline and business development Liquidity and cash flow
Revenue
$35.15M
▼ 1.5% YoY
Diluted EPS
$-0.42
▼ 200% YoY
Gross margin
28.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-01-02
Lifecore Biomedical, Inc. De (LFCR) Q2 2025 Earnings Call Transcript
Positive tone Revenue and EBITDA Growth Three-Pronged Growth Strategy Gross Margin and Operational Efficiency
Revenue
$32.56M
▲ 8% YoY
Diluted EPS
$-0.25
▼ 164.1% YoY
Gross margin
34.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-10-04
Lifecore Biomedical, Inc. De (LFCR) Q1 2025 Earnings Call Transcript
Confident tone Second-half weighted financial outlook New business wins and pipeline Capital raise and liquidity
Revenue
$24.70M
▲ 0.7% YoY
Diluted EPS
$-0.53
Gross margin
21.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-08-26
Lifecore Biomedical, Inc. De (LFCR) Q4 2024 Earnings Call Transcript
Positive tone FY24 revenue and profitability recovery Restructuring, recentralization and cost reduction CDMO services growth
Revenue
$37.88M*
▲ 21.6% YoY
Gross margin
45.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q4
2023-08-31
Lifecore Biomedical, Inc. De (LFCR) Q4 2023 Earnings Call Transcript
Revenue
$31.14M
▲ 10.8% YoY
Diluted EPS
$-1.32
Gross margin
25.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-03-16
Lifecore Biomedical, Inc. De (LFCR) Q3 2023 Earnings Call Transcript
Revenue
$26.54M
▼ 24.7% YoY
Diluted EPS
$-1.20
Gross margin
32.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-10-06
Lifecore Biomedical, Inc. De (LFCR) Q1 2023 Earnings Call Transcript
Revenue
$23.72M
▲ 6.2% YoY
Diluted EPS
$-0.37
Gross margin
25.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-08-10
Lifecore Biomedical, Inc. De (LFCR) Q4 2022 Earnings Call
Revenue
$28.11M
▼ 37.4% YoY
Diluted EPS
$-1.88
Gross margin
37.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-04-05
Lifecore Biomedical, Inc. De (LFCR) Q3 2022 Earnings Call
Revenue
$35.23M
▲ 26.7% YoY
Diluted EPS
$-0.46
Gross margin
33.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-01-05
Lifecore Biomedical, Inc. De (LFCR) Q2 2022 Earnings Call
Revenue
$25.60M
▲ 7.6% YoY
Diluted EPS
$-1.31
Gross margin
44.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-09-29
Lifecore Biomedical, Inc. De (LFCR) Q1 2022 Earnings Call
Revenue
$22.33M
▼ 1.5% YoY
Diluted EPS
$-0.32
Gross margin
24.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-07-28
Lifecore Biomedical, Inc. De (LFCR) Q4 2021 Earnings Call
Revenue
$44.92M
▼ 71.2% YoY
Gross margin
32.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-04-07
Lifecore Biomedical, Inc. De (LFCR) Q3 2021 Earnings Call
Revenue
$27.81M
▼ 81.8% YoY
Diluted EPS
$-0.24
Gross margin
39.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-01-06
Lifecore Biomedical, Inc. De (LFCR) Q2 2021 Earnings Call
Revenue
$23.79M
▼ 83.3% YoY
Diluted EPS
$-0.40
Gross margin
45.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-10-06
Lifecore Biomedical, Inc. De (LFCR) Q1 2021 Earnings Call
Revenue
$22.68M
▼ 83.7% YoY
Diluted EPS
$-0.42
Gross margin
23.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-08-11
Lifecore Biomedical, Inc. De (LFCR) Q4 2020 Earnings Call
Revenue
$156.13M
▲ 2.2% YoY
Gross margin
15.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-03-31
Lifecore Biomedical, Inc. De (LFCR) Q3 2020 Earnings Call
Revenue
$152.93M
▼ 1.7% YoY
Diluted EPS
$-0.39
▼ 1075% YoY
Gross margin
13.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-01-02
Lifecore Biomedical, Inc. De (LFCR) Q2 2020 Earnings Call
Revenue
$142.59M
▲ 14.5% YoY
Diluted EPS
$-0.23
Gross margin
10.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 webcasts
Key facts CIK 1005286 CUSIP 514766104 13F (30d) 10 filings 10 filers Visit website Investor relations